Tools
Tools
Bates, G, Hope, V and McVeigh, J (2017) HIV among people using anabolic steroid in the United Kingdom: an overview. HIV Nursing, 17 (1). ISSN 1474-7359
|
Text (Edited by Mel)
HIV N 17-1 compilation.pdf - Published Version Download (207kB) | Preview |
Abstract
Since the mid-1980s, preventing HIV transmission among people who inject drugs (PWIDs) has been one of the cornerstones of the UK’s response to HIV. The early comprehensive implementation of harm reduction, particularly needle and syringe programmes, has been widely acknowledged as key to a low prevalence of HIV among PWIDs in the UK. However, this harm-reduction strategy was developed to avert an HIV epidemic among people injecting heroin [1] and while the prevalence in this population remains low [2,3], it is clear that there are now emerging populations of PWIDs with different patterns of drug use and risks [4,5]. This article discusses one of these: anabolic steroid use in the context of HIV, and highlights the potential for the nursing profession to reduce HIV-transmission risk, and to improve the health of this diverse and vulnerable population through the use of existing knowledge and expertise.
| Item Type: | Article |
|---|---|
| Subjects: | R Medicine > RA Public aspects of medicine > RA0421 Public health. Hygiene. Preventive Medicine R Medicine > RT Nursing |
| Divisions: | Public Health Institute |
| Publisher: | Medisrcipt Ltd |
| Date Deposited: | 28 Apr 2017 10:49 |
| Last Modified: | 04 Sep 2021 11:45 |
| URI: | https://researchonline.ljmu.ac.uk/id/eprint/6148 |
 |
View Item |